FindTrial
Sign In

Muscle Preservation Hamstring Graft for ACL Reconstruction

Muscle Preservation Hamstring Graft for ACL Reconstruction: Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03998904
Enrollment
28
Registered
2019-06-26
Start date
2019-06-01
Completion date
2020-12-01
Last updated
2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graft Healing

Brief summary

* Muscle derived stem cell is a better source of stem cells than a tendon tissue * Preservation of muscle derived stem cell may enhance bone-tendon integration and ligamentization of ACL hamstring graft

Interventions

PROCEDUREMuscle preservation

Muscle preservation during graft preparation of hamstring graft

PROCEDURENo muscle preservation

No muscle preservation during graft preparation of hamstring graft

Sponsors

Hanyang University Seoul Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Primary ACL reconstruction using autogenous hamstring graft

Exclusion criteria

* Combined meniscal or ligament surgery * Combined osteoarthritis (KL grade II or more) * chondral injury more than grade 2 * Refuse to undergo MRI

Design outcomes

Primary

MeasureTime frameDescription
SNQ value of MRI6 monthssignal of ACL graft-signal of quadriceps tendon/singal of background

Countries

South Korea

Contacts

Primary ContactJIN KYU LEE, MD
gaia-silver@hnamail.net820222908485

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026